Genome Institute of Singapore (GIS)
Researchers extract insights from large databases of genetic and clinical information in a bid to develop more robust, data-driven breast cancer screening frameworks.
Genomic profiles of the human gut microbiome reveal the hidden impacts of asymptomatic, antibiotic-resistant bacterial infections, as well as potential solutions for their reversal.
With near-real-time genomic monitoring, researchers catch emergent, treatment-evading SARS-CoV-2 mutations in immunocompromised patients with chronic infections.
Unique gene signatures associated with drug-resistant leukaemia paves the way for improved clinical strategies to help these patients.
By exploring the genetic diversity within Escherichia coli bacteria, researchers uncover distinct gene families and a molecular weapon tied to disease-causing strains.
Scientists discover genes encoding colours, scents and bioactive compounds in the genome of Papilionanthe Miss Joaquim, Singapore’s National Flower.
Researchers have discovered a molecular pathway in colorectal cancer cells that leads to uncontrolled division, creating an avenue for more targeted therapies.
Using a new genome analysis technology, A*STAR scientists discover never-before-seen immune responses in tuberculosis infections.
Multidisciplinary efforts across A*STAR are paving the way toward Singapore’s precision medicine vision.
Through innovative molecular technologies, Jinyue Liu is building maps of the brain’s circuitry to better understand how these connections go awry in disease.
Experimental gene therapy promises a new lease of life for patients with genetic heart disease.